Add to ORKGIntroduction: The conventional aortic valve replacement is the treatment of choice for symptomatic severe aortic stenosis. Transcatheter technique is a viable alternative with promising results for inoperable patients. Sutureless bioprostheses have shown benefits in high-risk patients, such as reduction of aorti
Background: In this study, we present early-and mid-term results of sutureless bioprosthetic aortic ...
ObjectiveTranscatheter aortic valve implantation has been used to treat high-risk patients with biop...
ObjectivesThe CoreValve Extreme Risk US Pivotal Trial enrolled patients with symptomatic severe aort...
Aortic valve stenosis has become the most frequent type of valve disease in worldwide. Surgical aort...
With improving technologies and an increasingly elderly populations, there have been an increasing n...
Transcatheter aortic valve implantation (TAVI) and sutureless aortic valve replacement (SU-AVR) are ...
International audienceObjective: Sutureless aortic valves are a novel option for aortic valve replac...
Background: With improving technologies and an increasingly elderly populations, there have been an ...
To date, the gold standard of aortic stenosis treatment is surgical valve replacement. However, in i...
The advent of transcatheter aortic valve implantation (TAVI) has allowed many patients with severe a...
Sutureless valves became an alternative to standard bioprostheses, allowing surgeons to significantl...
AIMS: To critically review the available transcatheter aortic valve implantation techniques and thei...
Aortic stenosis remains the commonest form of valve disease in modern cardiology. With fifty years’ ...
Aims: To critically review the available transcatheter aortic valve implantation techniques and thei...
In the past decade, interventional cardiology has been revolutionized by transcatheter aortic valve ...
Background: In this study, we present early-and mid-term results of sutureless bioprosthetic aortic ...
ObjectiveTranscatheter aortic valve implantation has been used to treat high-risk patients with biop...
ObjectivesThe CoreValve Extreme Risk US Pivotal Trial enrolled patients with symptomatic severe aort...
Aortic valve stenosis has become the most frequent type of valve disease in worldwide. Surgical aort...
With improving technologies and an increasingly elderly populations, there have been an increasing n...
Transcatheter aortic valve implantation (TAVI) and sutureless aortic valve replacement (SU-AVR) are ...
International audienceObjective: Sutureless aortic valves are a novel option for aortic valve replac...
Background: With improving technologies and an increasingly elderly populations, there have been an ...
To date, the gold standard of aortic stenosis treatment is surgical valve replacement. However, in i...
The advent of transcatheter aortic valve implantation (TAVI) has allowed many patients with severe a...
Sutureless valves became an alternative to standard bioprostheses, allowing surgeons to significantl...
AIMS: To critically review the available transcatheter aortic valve implantation techniques and thei...
Aortic stenosis remains the commonest form of valve disease in modern cardiology. With fifty years’ ...
Aims: To critically review the available transcatheter aortic valve implantation techniques and thei...
In the past decade, interventional cardiology has been revolutionized by transcatheter aortic valve ...
Background: In this study, we present early-and mid-term results of sutureless bioprosthetic aortic ...
ObjectiveTranscatheter aortic valve implantation has been used to treat high-risk patients with biop...
ObjectivesThe CoreValve Extreme Risk US Pivotal Trial enrolled patients with symptomatic severe aort...